Evercore ISI Maintains Outperform, $126 Target On Medtronic As Firm Notes The American College Of Cardiology Late Breaker Agenda Implies Medtronic's Spyral Off-Med pivotal RCT Data 'trial hit superiority - a clear positive for MDT!'